会计政策变更

Search documents
深圳市智微智能科技股份有限公司2025年半年度报告摘要
Shang Hai Zheng Quan Bao· 2025-07-30 18:47
Core Viewpoint - The company has approved its 2025 semi-annual report and related resolutions during the board meeting, ensuring compliance with legal and regulatory requirements [10][12][45]. Company Basic Information - The company is Shenzhen Zhimi Intelligent Technology Co., Ltd., with stock code 001339 [10]. - The board of directors and the supervisory board have confirmed the accuracy and completeness of the information disclosed [10][43]. Financial Data and Indicators - The company reported a total fundraising amount of 1,041.11 million yuan from its initial public offering, with a net amount of 951.18 million yuan after deducting issuance costs [52]. - As of June 30, 2025, the company has an unused fundraising balance of 212.06 million yuan, with 32.06 million yuan in special accounts and 130 million yuan in high-security bank deposits [81]. Board Meeting Resolutions - The board approved the semi-annual report and its summary with unanimous votes [12][45]. - The board also approved the renewal of the accounting firm Tianjian for the 2025 fiscal year, pending shareholder approval [16][84]. - The board agreed to increase the expected amount for daily related transactions by 500 million yuan for purchasing raw materials and 3 million yuan for leasing properties [20]. Changes in Company Structure - There were no changes in the controlling shareholder or actual controller during the reporting period [7]. - The company plans to amend its registered capital and business scope, requiring shareholder approval [22]. Internal Regulations - The company has revised several internal regulations to enhance governance, including rules for shareholder meetings and board meetings [25][37]. - The board approved the establishment of new internal management systems, which will take effect after shareholder approval [37]. Related Transactions - The company has increased the expected amount for daily related transactions, ensuring compliance with market principles and maintaining independence [47]. Fund Management - The company has established a fundraising management system to ensure the proper use of raised funds, with strict adherence to regulatory requirements [55]. - The company has signed multiple fundraising supervision agreements with banks to ensure the safety and efficiency of fund management [57][58]. Future Meetings - The company plans to hold its second extraordinary general meeting of 2025 on August 19, 2025 [40].
智微智能: 2025年半年度报告摘要
Zheng Quan Zhi Xing· 2025-07-30 16:45
0 不适用 0 东台智展企业管理合伙企 境内非国有 业(有限合伙) 法人 中国银行股份有限公司- 易方达供给改革灵活配置 其他 0.32% 797,700 0 不适用 0 混合型证券投资基金 中国农业银行股份有限公 司-宝盈策略增长混合型 其他 0.30% 756,999 0 不适用 0 证券投资基金 招商银行股份有限公司- 南方中证 1000 交易型开放 其他 0.28% 698,100 0 不适用 0 式指数证券投资基金 | 深圳市智微智能科技股份有限公司 | 2025 年半年度报告摘要 | | | | | --- | --- | --- | --- | --- | | 证券代码:001339 证券简称:智微智能 | 公告编号:2025-066 | | | | | 深圳市智微智能科技股份有限公司 | | | | | | | 深圳市智微智能科技股份有限公司 | 2025 | 年半年度 | | | 报告摘要 | | | | | | 一、重要提示 | | | | | | 本半年度报告摘要来自半年度报告全文,为全面了解本公司的经营成果、财务状况及未来发展规划,投 | | | | | | 资者应当到证监 | | | ...
英科医疗: 财务报告管理制度
Zheng Quan Zhi Xing· 2025-07-08 16:12
Core Points - The company establishes a financial reporting internal control system to ensure the authenticity and reliability of financial information, enhance corporate governance, and protect shareholder rights [1][2] - The financial reporting internal control applies to the company and its wholly-owned and controlled subsidiaries [1] - The financial report includes accounting statements and related disclosures, ensuring compliance with accounting laws and regulations [1][2] Management Responsibilities - The finance department is responsible for the preparation and management of financial reports, including collecting accounting information and compiling financial analysis reports [3] - The board of directors and senior management collectively ensure the authenticity and completeness of the financial reports [3][4] - Specific responsibilities are assigned to various departments to ensure accurate financial accounting and reporting [3][4] Major Financial Matters - The company adopts accounting policies based on relevant accounting standards and guidelines, with changes requiring approval from the board of directors [11][12] - Significant accounting estimates must be reviewed and approved, with any changes communicated to relevant stakeholders [7][8] - Major financial matters are assessed and reported, including impacts on financial statements and compliance with regulations [8][9] Financial Report Preparation - The finance department is tasked with preparing annual financial reports, ensuring compliance with accounting standards and legal requirements [18][19] - Accurate accounting records must be maintained, and any discrepancies must be addressed promptly [19][20] - The company must conduct asset verification and ensure all financial transactions are recorded accurately [20][21] Financial Reporting and Submission - The company must submit financial reports in a timely manner, ensuring all documents are properly formatted and signed [15][16] - Any errors in submitted reports must be corrected and communicated to relevant parties [15][16] - Financial analysis reports are prepared semi-annually to evaluate the company's performance and financial health [35][36] Financial Analysis - Financial analysis aims to evaluate the company's operational performance and profitability, identifying key influencing factors [35][36] - The analysis includes various financial ratios to assess liquidity, operational efficiency, and profitability [36][37] - The finance department is responsible for compiling and presenting financial analysis reports to the board [35][36]
股市必读:中粮资本(002423)7月7日董秘有最新回复
Sou Hu Cai Jing· 2025-07-07 18:30
Group 1 - The company, COFCO Capital (002423), closed at 12.15 yuan on July 7, 2025, with an increase of 1.33% and a turnover rate of 1.23% [1] - The trading volume was 283,200 shares, with a total transaction amount of 344 million yuan on the same day [1] - On July 7, the net inflow of main funds was 16.44 million yuan, indicating a certain level of market interest in the stock [3] Group 2 - The company announced a change in accounting policies on April 30, 2025, which will be implemented from January 1, 2025, in compliance with the Ministry of Finance's standards [2] - The change primarily involves reclassification of insurance contract income recognition and liability measurement, enhancing transparency without affecting actual operating results, premium scale, or cash flow [2][1] - The first quarter report for 2025 has been adjusted to reflect the new standards, ensuring comparability with the previous year's data [2]
中欣氟材: 关于最近五年公司被证券监督管理部门和交易所采取监管措施或处罚及整改情况的公告
Zheng Quan Zhi Xing· 2025-07-07 14:13
Core Viewpoint - Zhejiang Zhongxin Fluorine Material Co., Ltd. has not faced any penalties from regulatory authorities in the last five years, but received a warning letter regarding internal control and disclosure issues [1][5]. Summary by Sections Regulatory Penalties - The company has not been penalized by the securities regulatory authorities or exchanges in the last five years [1]. Regulatory Measures and Rectification - The company received a warning letter from the Zhejiang Securities Regulatory Bureau, citing issues related to accounting policy changes at its wholly-owned subsidiary, Fujian Zhongxin Fluorine Material Gaobao Technology Co., Ltd. [2][3]. - The warning letter highlighted that the company failed to disclose changes in inventory cost accounting methods and did not follow the necessary review procedures [2]. - Additional issues included non-compliance in revenue, cost, and expense recognition, as well as inadequate internal controls [3]. - Key personnel, including the chairman and financial director, were held responsible for these violations and were issued warning letters [3]. Response and Improvement Measures - Following the warning letter, the company held board meetings to address the issues and approved a resolution to change the accounting policy in compliance with regulatory requirements [5]. - The company has committed to enhancing its legal and regulatory knowledge among its management and staff to ensure compliance and improve operational standards [5]. - No other regulatory measures have been issued against the company in the last five years apart from the warning letter [5].
安源煤业: 安源煤业集团股份有限公司备考财务报表审阅报告
Zheng Quan Zhi Xing· 2025-06-27 16:47
Company Overview - Anyuan Coal Industry Group Co., Ltd. was approved by the Jiangxi Provincial Government and officially listed on the Shanghai Stock Exchange on July 2, 2002, with stock code 600397 [1][2] - The company has a registered capital of RMB 989,959,882 and is primarily engaged in coal mining, sales of coal and products, material trade, and other related activities [2] Major Asset Restructuring - The company plans to swap its coal-related assets and liabilities with Jiangxi Jiangtong Holdings Development Co., Ltd. for an equivalent portion of shares in Ganzhou Jinhui Magnetic Separation Technology Equipment Co., Ltd., which Jiangtong holds 57% [2][3] - The transaction will involve a cash adjustment for the difference in the transaction prices of the assets being swapped, with the proposed price for the assets to be disposed of at RMB 369.77 million and the assets to be acquired at RMB 368.70 million, resulting in a cash payment of RMB 1.0724 million from Jiangtong to the company [6][7] Financial Reporting - The preparation of the pro forma consolidated financial statements is based on the relevant regulations of the China Securities Regulatory Commission regarding major asset restructuring [5] - The financial statements reflect the company's financial position as of December 31, 2024, and the operating results for the year, assuming the transaction was completed on January 1, 2024 [6][7] Accounting Policies - The company adopts specific accounting policies and estimates based on its operational characteristics, ensuring compliance with relevant accounting standards [8] - The financial statements are prepared using the RMB as the functional currency, and the company follows a 12-month operating cycle for liquidity classification [8][19] Financial Asset Management - Financial assets are classified based on the business model and cash flow characteristics, including those measured at amortized cost and those measured at fair value [22][23] - The company recognizes expected credit losses for financial assets measured at amortized cost and those measured at fair value, applying a general or simplified approach based on credit risk assessments [29][30]
津膜科技: 关于公司会计政策变更的公告
Zheng Quan Zhi Xing· 2025-05-13 11:13
证券代码:300334 证券简称:津膜科技 公告编码:2025-040 定了"关于流动负债与非流动负债的划分"、" 关于供应商融资安排的披露"、"关于 售后租回交易的会计处理"的内容,该解释规定自 2024 年 1 月 1 日起执行。 定了"关于不属于单项履约义务的保证类质量保证的会计处理"的内容,该解释规定自印 发之日起施行,允许企业自发布年度提前执行。 天津膜天膜科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没 有虚假记载、误导性陈述或重大遗漏。 特别提示: 天津膜天膜科技股份有限公司(以下简称"公司")根据财政部颁布的《企业会计准 则解释第 17 号》(财会202321 号)及《企业会计准则解释第 18 号》(财会202424 号) 的相关要求,变更公司有关会计政策。本次会计政策变更对公司报表无影响。 根据《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 等有关规定,公司本次会计政策变更是公司依据法律法规和国家统一的会计制度要求进行 的变更,不属于公司自主变更会计政策的情形,不会导致公司已披露的年度财务报告出现 盈亏性质改变,未对公司当期的财务状况 ...
中国瑞林: 2024年度股东大会会议材料
Zheng Quan Zhi Xing· 2025-05-13 09:15
Core Viewpoint - The company is preparing for its 2024 Annual General Meeting (AGM) scheduled for May 19, 2025, focusing on various proposals including financial reports, compensation plans, and governance matters [1][2][3]. Group 1: Meeting Proposals - Proposal 1 includes the confirmation of the 2024 Board of Directors' work report, highlighting a revenue of CNY 2,475.60 million, a decrease of 13.63% compared to the previous year, while net profit attributable to shareholders increased by 2.62% to CNY 152.02 million [4][5][6]. - Proposal 2 addresses the 2024 Supervisory Board work report, emphasizing the board's compliance with legal regulations and its role in safeguarding shareholder interests [15][16]. - Proposal 3 presents the 2024 financial settlement report, which has been audited and reflects the company's financial status accurately [19][20]. Group 2: Financial Performance - The company reported a total asset of CNY 5,196.01 million and a liability of CNY 3,304.10 million, resulting in a debt-to-asset ratio of 63.59% [6][20]. - The operating income for 2024 was CNY 2,475.60 million, with a net cash flow from operating activities of CNY 172.46 million, down 13.63% from the previous year [20][22]. - The company plans to distribute CNY 60 million in cash dividends, representing 39.47% of the net profit attributable to shareholders [27][28]. Group 3: Governance and Compliance - The company has established a governance structure that complies with the Company Law and Securities Law, ensuring transparency and accountability in its operations [10][15]. - The Supervisory Board conducted five meetings during the reporting period, ensuring that all decisions made by the Board of Directors were in line with legal requirements [15][16]. - The company intends to continue its relationship with Tianjian Accounting Firm for the 2025 audit, ensuring ongoing compliance and oversight [30].
2025年一季度,康佳集团营收微增、利润暴增的背后,并不是公司主营
Xin Lang Cai Jing· 2025-05-13 02:43
主营业务已经连亏14年的康佳集团,进入2025年一季度,仍然没有扭转主业继续亏损的局面。在2025 年,迎来了新股东华润的康佳集团,又能否改变主业亏损的局面? 2025年一季度,康佳集团财报显示:公司营业总收入为25.44亿元,较上年同期的24.63亿元增长 3.32%;归母净利润为9481.07万元,而上年同期为亏损5.10亿元,同比增长118.59%,成功实现扭亏为 盈。 2025年一季度,康佳集团营收微增、利润暴增的背后,并不是公司主营业务的经营质量得到了显著改 善,而是继续通过变更会计政策的方式赚了5.35亿元,避免公司归母净利润继续亏损的尴尬。问题是, 以周彬为首的康佳集团管理层,还有多少资产可卖、多少会计政策可变更,来弥补公司主营业务持续亏 损的尴尬? 孙力||撰稿 相对于2024年财报,2025年一季度,康佳集团似乎实现了经营业绩的快速、大幅度改善。不过,家电圈 却看到:今年一季度康佳集团的扭亏为盈,凭借的不是主营业务赚钱了,而是继续进行公司的投资资产 运营,即非经常性损益。对于企业来说,这种操作存在很大的不确定性,毕竟可以腾挪的资产毕竟是有 限的,主业如果迟迟找不到扭亏的方向和手段,公司是难以 ...
浙江诚意药业股份有限公司
Shang Hai Zheng Quan Bao· 2025-04-30 14:52
Group 1 - The company held its fourth board meeting on April 28, 2025, where it approved changes to its accounting policies without requiring shareholder approval [1][6][40] - The change in accounting policy is due to the Ministry of Finance's issuance of Interpretation No. 18, which clarifies the reporting of warranty-related costs [1][3][4] - The new accounting policy will be implemented starting December 6, 2024, and aims to provide a more objective and fair representation of the company's financial status and operating results [1][5][4] Group 2 - The company has proposed to elect a new board of directors, consisting of nine members, including six non-independent directors and three independent directors [9][10][11] - The election of the new board is scheduled to be presented at the 2024 annual general meeting [9][10][11] - The company will hold a staff representative meeting on May 20, 2025, to elect one staff representative director [10] Group 3 - The company has received approval from the National Medical Products Administration for the marketing of the chemical raw material drug, Dobutamine Hydrochloride [34][36] - This approval allows the company to produce and sell the drug domestically, which is used in the treatment of cardiovascular diseases [34][36][37] - The company has invested approximately RMB 5.1982 million in the research and development of this raw material drug [37] Group 4 - The company has proposed a profit distribution plan, intending to distribute cash dividends of RMB 0.25 per share, totaling approximately RMB 79.42 million [99][102] - The proposed cash dividend represents 39.57% of the company's net profit attributable to shareholders for the year [102] - The profit distribution plan is subject to approval at the upcoming shareholder meeting [102][105] Group 5 - The company has decided to cancel its supervisory board, transferring its responsibilities to the audit committee of the board [109][110] - This decision aligns with recent amendments to the Company Law and aims to streamline governance [109][110] - The relevant rules and regulations will be revised accordingly to reflect this change [109][110]